Want to see GB:FORF full AI Analyst Report?
Top Page
MyHealthChecked PLC
(LSE:FORF)
Select Model
Select Model
Rating:46Neutral
Price Target:
8.00 p
▼(-2.44% Downside)
Action:Reiterated
Date:08/04/26
The score is primarily constrained by sharply weakened fundamentals (revenue collapse to effectively zero, multi-year losses, and negative operating/free cash flow). Technicals are neutral-to-soft with little trend strength, and valuation signals are weak due to negative earnings and no stated dividend yield. Corporate events are mixed, with buybacks offset by elevated risk from the announced AIM suspension and uncertainty around completing a qualifying transaction.
Positive Factors
Low leverage / near-zero debt
A near-zero debt position provides durable financial flexibility: lower interest burden and fewer covenant constraints reduce the risk of insolvency while the company restructures. This preserves strategic optionality to raise capital or execute partnerships without immediate refinancing pressure.
Negative Factors
Severe revenue collapse
A collapse to effectively zero revenue is a structural impairment: it destroys economies of scale, disables margin recovery, and limits ability to cover fixed lab and processing costs. Restoring sustainable top-line is prerequisite for durable profitability, making recovery challenging and time-consuming.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / near-zero debt
A near-zero debt position provides durable financial flexibility: lower interest burden and fewer covenant constraints reduce the risk of insolvency while the company restructures. This preserves strategic optionality to raise capital or execute partnerships without immediate refinancing pressure.
Read all positive factors
MyHealthChecked PLC (FORF) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£2.65M
Dividend YieldN/A
Average Volume (3M)35.18K
Price to Earnings (P/E)―
Beta (1Y)1.08
Revenue GrowthN/A
EPS GrowthN/A
CountryUK
Employees13
SectorFinancial
Sector Strength70
IndustryMedical - Specialties
Share Statistics
EPS (TTM)-0.04
Shares Outstanding32,451,977
10 Day Avg. Volume35,100
30 Day Avg. Volume35,181
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)0.72
Price to Sales (P/S)0.00
P/FCF Ratio-2.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MyHealthChecked PLC Business Overview & Revenue Model
Company Description
Fortis Frontier PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom. It is also involved in the development of an accompanying proprietary digital platform. The company was formerly known as My...
How the Company Makes Money
null...
MyHealthChecked PLC Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
62
Positive
Cash Flow
22
Negative
| Breakdown | TTM | Dec 2025 | Jun 2025 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.58M | 0.00 | 3.61M | 10.98M | 22.31M | 16.38M |
| Gross Profit | -392.00K | -215.00K | -194.00K | 2.05M | 4.79M | 5.13M |
| EBITDA | -2.10M | -360.00K | -1.53M | 30.00K | 1.74M | 2.16M |
| Net Income | -2.24M | -1.63M | -1.79M | -159.00K | 1.52M | 2.00M |
Balance Sheet | ||||||
| Total Assets | 8.41M | 7.53M | 8.80M | 13.34M | 11.43M | 11.67M |
| Cash, Cash Equivalents and Short-Term Investments | 5.06M | 5.76M | 5.47M | 7.75M | 7.61M | 6.39M |
| Total Debt | 0.00 | 0.00 | 0.00 | 26.00K | 53.00K | 0.00 |
| Total Liabilities | 2.78M | 2.15M | 1.83M | 4.64M | 2.58M | 4.55M |
| Stockholders Equity | 5.63M | 5.38M | 6.97M | 8.70M | 8.85M | 7.11M |
Cash Flow | ||||||
| Free Cash Flow | -1.19M | -1.62M | -2.26M | 157.00K | 1.27M | 2.77M |
| Operating Cash Flow | -1.16M | -1.62M | -2.16M | 724.00K | 1.61M | 3.01M |
| Investing Cash Flow | -103.00K | 1.91M | -93.00K | -531.00K | -338.00K | -299.00K |
| Financing Cash Flow | -13.50K | 0.00 | -23.00K | -52.00K | -47.00K | 3.21M |
MyHealthChecked PLC Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | £14.89M | -104.35 | 0.08% | ― | ― | ― | |
59 Neutral | £110.60M | 54.68 | 3.01% | ― | 2.73% | -65.94% | |
58 Neutral | £59.51M | 10.35 | 9.56% | ― | ― | ― | |
55 Neutral | £4.66M | -5.00 | -11.04% | ― | -2.87% | 52.38% | |
53 Neutral | £16.59M | -15.95 | -6.49% | ― | 24.30% | 93.53% | |
46 Neutral | £2.65M | -2.63 | -34.26% | ― | ― | ― |
* Financial Sector Average
GB:FORF
MyHealthChecked PLC
8.20
-2.30
-21.90%
GB:RUA
RUA Life Sciences
24.00
11.88
97.94%
GB:CREO
Creo Medical
12.75
-0.38
-2.86%
GB:EKF
EKF Diagnostics Holdings
26.00
-4.10
-13.62%
GB:IHC
Inspiration Healthcare
18.50
-2.50
-11.90%
GB:SUN
Surgical Innovations
0.50
-0.20
-28.57%
MyHealthChecked PLC Corporate Events
Business Operations and Strategy
Fortis Frontier Relocates Registered Office as Cash Shell Evaluates Strategic Options
Neutral
May 14, 2026
Fortis Frontier PLC, formerly MyHealthChecked PLC, operates as an AIM Rule 15 cash shell after selling its diagnostics subsidiary, Concepta Diagnostics Limited, and now has no active trading business while its board reviews strategic paths to enha...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Fortis Frontier Cuts Share Count as AIM Cash Shell Eyes Next Move
Positive
May 11, 2026
Fortis Frontier PLC, an AIM Rule 15 cash shell formerly known as MyHealthChecked PLC, became a non-trading vehicle after selling its diagnostics subsidiary in late 2025 and is currently reviewing strategic options to enhance shareholder returns. T...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Fortis Frontier Tightens Share Base With Buyback as Cash Shell Weighs Strategic Options
Positive
May 7, 2026
Fortis Frontier PLC, an AIM-listed cash shell formerly operating as MyHealthChecked PLC in the healthcare diagnostics space, became a Rule 15 cash shell after selling its trading subsidiary and rebranding in November 2025. The board is currently a...
Business Operations and StrategyStock Buyback
Fortis Frontier Cuts Share Count with Buyback as It Weighs New Strategy
Positive
May 7, 2026
Fortis Frontier PLC, an AIM Rule 15 cash shell that previously operated as MyHealthChecked PLC in the consumer diagnostics space, is focused on identifying and executing new strategic opportunities after disposing of its former trading subsidiary....
Business Operations and StrategyStock Buyback
Fortis Frontier Cuts Share Capital with Buyback and Cancellation
Neutral
May 6, 2026
Fortis Frontier PLC, an AIM Rule 15 cash shell formerly known as MyHealthChecked PLC, operates without an active trading subsidiary after selling Concepta Diagnostics Limited in late 2025. The company is currently assessing strategic alternatives ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.